Roche Holding AG (FRA:RHO0) FFO


FRA:RHO0 Roche Holding AG FRA:RHO0
77 GF Score
Price €16.30
GF Value €12.84
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG FFO?

FFO (Funds from operations) only applies to REITs.

FRA:RHO0
77GF Score
Roche Holding AG FRA:RHO0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (FRA:RHO0) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of €16.30 is trading 26.9% above its estimated GF Value™ of €12.84.

Key valuation signals for FRA:RHO0:

  • FFO:
  • GF Value™: €12.84 vs. price of €16.30 (26.9% above fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the FRA:RHO0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
77GF Score

Get the complete analysis for FRA:RHO0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.30
Price
€12.84
GF Value